| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 24.07B | 23.03B | 20.84B | 19.33B | 18.66B | 18.11B |
| Gross Profit | 14.21B | 23.03B | 20.84B | 19.33B | 18.66B | 18.11B |
| EBITDA | 4.38B | 3.86B | 1.00B | 979.00M | 2.21B | 2.55B |
| Net Income | 1.92B | 1.35B | -828.00M | -443.00M | 235.00M | 574.00M |
Balance Sheet | ||||||
| Total Assets | 90.51B | 70.85B | 60.28B | 55.40B | 53.04B | 44.92B |
| Cash, Cash Equivalents and Short-Term Investments | 23.12B | 17.04B | 10.81B | 10.56B | 12.12B | 8.30B |
| Total Debt | 7.96B | 10.54B | 8.54B | 8.46B | 6.08B | 6.88B |
| Total Liabilities | 69.58B | 51.62B | 42.50B | 36.94B | 34.40B | 34.41B |
| Stockholders Equity | 20.87B | 19.17B | 17.70B | 18.37B | 18.64B | 10.51B |
Cash Flow | ||||||
| Free Cash Flow | 9.13B | 5.02B | 191.00M | -4.07B | 143.00M | 5.66B |
| Operating Cash Flow | 9.15B | 6.57B | 1.93B | -2.63B | 951.00M | 6.35B |
| Investing Cash Flow | -1.71B | -1.51B | -1.76B | -1.76B | -767.00M | -894.00M |
| Financing Cash Flow | 1.56B | 1.21B | 75.00M | 2.84B | 3.63B | -1.89B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
84 Outperform | ¥74.57B | 21.69 | ― | 2.02% | 13.52% | 7.75% | |
73 Outperform | ¥657.22B | 7.04 | 9.13% | 2.79% | 20.96% | 22.58% | |
69 Neutral | ¥750.56B | 10.93 | 7.97% | 3.48% | 6.65% | -4.35% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
67 Neutral | ¥185.85B | 9.94 | ― | 4.42% | 2.13% | -25.62% | |
61 Neutral | ¥559.48B | 21.83 | 11.30% | 3.66% | 8.02% | 19.35% | |
59 Neutral | ¥35.41B | 20.82 | ― | ― | 13.25% | 1251.39% |